Ballard Spahr LLP
Podoviriedae bacteriophage having killing activity specific to Staphylococcus aureus 
The present invention relates to a novel bacteriophage, more precisely a Podoviridae bacteriophage having killing activity specific to Staphylococcus aureus which is the causing agent of infectious disease in human and animals, a pharmaceutical composition for the prevention and treatment of the disease caused by Staphylococcus aureus, an antibiotic and a disinfectant containing the bacteriophage as an active ingredient.
iNtRON Biotechnology, Inc.
C A C A
C12N A61P C12N A61K
additional inventional inventional inventional
Yunjaie Jeesoo Seongjun Sanghyeon Sooyoun Seyung
Choi Son Yoon Kang Jun Lee